Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

Antibody Engineering & Therapeutics Europe
1 - 3 June, 2027
Congress CenterBasel Switzerland
Menu

Dr. Aude Segaliny, PhD
VP of Research & Development at Amberstone Biosciences
Speaker

Profile

Dr. Aude Segaliny, founding scientist and Vice President of Research & Development at Amberstone Biosciences, pioneers next-generation therapeutics with enhanced precision and a markedly improved therapeutic window. Her work is dedicated to advancing safer, more potent treatment options for patients that surpass current standards of care.

Agenda Sessions

  • Redefining TCEs for Solid Tumors: Precision Safety, Efficacy Unlocked

    , 14:45
    View Session

At this event

Prev
Next
Niccolo Pengo, PhD
Chief Scientific Officer
Mabylon AG

See Aude at Antibody Engineering & Therapeutics Europe